These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 10893688

  • 1. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.
    Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J.
    J Bone Miner Res; 2000 Jul; 15(7):1384-92. PubMed ID: 10893688
    [Abstract] [Full Text] [Related]

  • 2. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group.
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [Abstract] [Full Text] [Related]

  • 3. The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO).
    Koçyigit H, Gülseren S, Erol A, Hizli N, Memis A.
    Clin Rheumatol; 2003 Feb; 22(1):18-23. PubMed ID: 12605312
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL, Shen W, Minshall ME, Xie S, Moses KH.
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [Abstract] [Full Text] [Related]

  • 5. Relationship between health-related quality of life domains and bone status in postmenopausal Japanese women.
    Tashiro A, Kakuta H, Tanaka N, Takeuchi Y.
    Menopause; 2006 Jan; 13(5):846-9. PubMed ID: 16894337
    [Abstract] [Full Text] [Related]

  • 6. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures.
    Romagnoli E, Carnevale V, Nofroni I, D'Erasmo E, Paglia F, De Geronimo S, Pepe J, Raejntroph N, Maranghi M, Minisola S.
    Osteoporos Int; 2004 Dec; 15(12):975-80. PubMed ID: 15118812
    [Abstract] [Full Text] [Related]

  • 7. Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide.
    Crans GG, Silverman SL, Genant HK, Glass EV, Krege JH.
    Arthritis Rheum; 2004 Dec; 50(12):4028-34. PubMed ID: 15593198
    [Abstract] [Full Text] [Related]

  • 8. Impact of recent fracture on health-related quality of life in postmenopausal women.
    Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES.
    J Bone Miner Res; 2006 Jun; 21(6):809-16. PubMed ID: 16753011
    [Abstract] [Full Text] [Related]

  • 9. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
    Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL.
    J Rheumatol; 2003 Jul; 30(7):1579-83. PubMed ID: 12858462
    [Abstract] [Full Text] [Related]

  • 10. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures.
    Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P.
    Osteoporos Int; 2005 Aug; 16(8):861-70. PubMed ID: 15558238
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the functioning of women with osteoporosis with vertebral fractures and without vertebral fractures using the Polish version of Qualeffo-41].
    Baczyk G, Opala T, Klejewski A, Tesarska B.
    Chir Narzadow Ruchu Ortop Pol; 2010 Aug; 75(3):172-7. PubMed ID: 21038636
    [Abstract] [Full Text] [Related]

  • 12. Quality of life in osteoporotic women with inadequate clinical response to antiresorptive drugs: results from the ICARO study.
    Barbagallo M, Dominguez LJ, Maugeri D, Isaia G, Silvestri S, Bevilacqua M, Adami S, ICARO Study Group.
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):24-7. PubMed ID: 18180604
    [Abstract] [Full Text] [Related]

  • 13. Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis.
    Leidig-Bruckner G, Minne HW, Schlaich C, Wagner G, Scheidt-Nave C, Bruckner T, Gebest HJ, Ziegler R.
    J Bone Miner Res; 1997 Apr; 12(4):663-75. PubMed ID: 9101379
    [Abstract] [Full Text] [Related]

  • 14. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR, Continuing Outcomes Relevant to Evista (CORE) Investigators.
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [Abstract] [Full Text] [Related]

  • 15. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.
    Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Kellingray S, Leplege A, Liberman UA, McCloskey E, Minne H, Reeve J, Reginster JY, Scholz M, Todd C, de Vernejoul MC, Wiklund I.
    Osteoporos Int; 1999 Sep; 10(2):150-60. PubMed ID: 10501796
    [Abstract] [Full Text] [Related]

  • 16. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

  • 17. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.
    Silverman SL, Minshall ME, Shen W, Harper KD, Xie S, Health-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study.
    Arthritis Rheum; 2001 Nov; 44(11):2611-9. PubMed ID: 11710717
    [Abstract] [Full Text] [Related]

  • 18. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.
    Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD.
    J Bone Miner Res; 2002 Jan; 17(1):1-10. PubMed ID: 11771654
    [Abstract] [Full Text] [Related]

  • 19. Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review.
    Wilson S, Sharp CA, Davie MW.
    Osteoporos Int; 2012 Dec; 23(12):2749-68. PubMed ID: 22814944
    [Abstract] [Full Text] [Related]

  • 20. [The impact of vertebral fractures on quality of life in postmenopausal women with osteoporosis. Validity of the Italian version of mini-Osteoporosis Quality of Life Questionnaire.].
    Salaffi F, Stancati A, Carotti M, Lorenzetti R, Grassi W.
    Reumatismo; 2005 Dec; 57(2):83-96. PubMed ID: 15983631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.